rs746518411
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003383.5(VLDLR):c.1667G>A(p.Arg556Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000122 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003383.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251376Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135854
GnomAD4 exome AF: 0.000123 AC: 180AN: 1461854Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 89AN XY: 727224
GnomAD4 genome AF: 0.000112 AC: 17AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.1667G>A (p.R556Q) alteration is located in exon 11 (coding exon 11) of the VLDLR gene. This alteration results from a G to A substitution at nucleotide position 1667, causing the arginine (R) at amino acid position 556 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 556 of the VLDLR protein (p.Arg556Gln). This variant is present in population databases (rs746518411, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with VLDLR-related conditions. ClinVar contains an entry for this variant (Variation ID: 437222). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 Uncertain:1
The missense variant in c.1667G>A(p.Arg556Gln) in VLDLR gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Arg556Gln variant is novel (not in any individuals) in 1000 Genomes and has allele frequency of 0.02% in gnomAD database. This variant has been reported to the ClinVar database as Variant of Uncertain Significance (VUS). The amino acid change p.Arg556Gln in VLDLR is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Arg at position 556 is changed to a Gln changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Uncertain Significance (VUS). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at